1[1]Barlund M,Forozan F,Kononen J,et al. Detecting activation of ribosomal protein s6 kinase by complementary DNA and tissue microarrays analysis [J]. J Natl Cancer Inst, 2000, 92 (15):1252-1259.
2[2]Dhanasekaran SM,Barrette TR,Ghosh D,et al. Delineation of prognostic biomarkers in prostate cancer[J]. Nature, 2001,412(6849) : 822-826.
3[3]Sallinen SL,Sallinen PK,Haapasalo HK,et al. Identification of differentially expressed gene in human gliomas by cDNA microarray and tissue chip techniques [J]. Cancer Res, 2000, 60(23):6617-6622.
4[4]Schraml P, Kononen J,Bubendorf l,et al. Tissue microarrays for gene amplification surveys in many different tumor types[J]. Clin Cancer Res, 1999,5 (8):1966-1975.
5[5]Moch H,Schraml P,Bubendorf L,et al. High throughput tissue microarray analysis to evaluate the significance of gene uncovered by cDNA microarray screening in renal cell carcinoma[J].Am J Pathol, 1999,154: 981-986.
6Mccutcheon IE.Flyvbjerg A,Hill H,et al.Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.J Neurosurg,2001,94(3):487-492.
7Roser F,Nakamura M,Bellinzona M,et al.The prognostic value of progesterone receptor status in meningiomas.J Clin Pathol,2004,57(10):1033-1037.
8Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrys for high throughput molecular profiling of tumor,specimens.Nat Med,1998,4(7):844-847.
9Hirota Y,Tachibanab O,Uchiyamaa N,et al.Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.Clinical Neurology and Neurosurgery,2009,111(2):127-133.
